Skip to main content

Articles

Page 2 of 14

  1. The Covid-19 pandemic has had serious medical, administrative and financial effects on the health system and hospitals around the world. In Türkiye, compared to 2019 realizations, in 2020 and 2021 respectively...

    Authors: Seher Nur Sülkü, Alper Mortaş and Aziz Küçük
    Citation: Cost Effectiveness and Resource Allocation 2023 21:70
  2. The global increase in mean body mass index has resulted in a substantial increase of non-communicable diseases (NCDs), including in many low- and middle-income countries such as Kenya. This paper assesses fou...

    Authors: Mary Njeri Wanjau, Lucy W. Kivuti-Bitok, Leopold N. Aminde and J. Lennert Veerman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:69
  3. Tuberculosis (TB) is a communicable disease that is a major cause of death and one of the leading causes of death worldwide. Currently, there is no analyzed data to examine the financial profile of TB by count...

    Authors: Maryam Meskini, Nahid Madadi, Kamal Ahmadi, Farzam Vaziri, Abolfazl Fateh and Seyed Davar Siadat
    Citation: Cost Effectiveness and Resource Allocation 2023 21:68
  4. The use of peripherally inserted central catheters and midline catheters is growing due to their potential benefits. These devices can increase patient safety and satisfaction while reducing the use of resourc...

    Authors: Laura Ricou Ríos, Candela Esposito Català, Arnau Pons Calsapeu, Cristina Adroher Mas, Isabel Andrés Martínez, Isaac Nuño Ruiz, Mònica Castellà Creus, Laia Castellà Fàbregas, Maria José García Quesada, Oriol Estrada Cuxart, Jordi Ara del Rey and Francesc López Seguí
    Citation: Cost Effectiveness and Resource Allocation 2023 21:67
  5. In an effort to minimize positive margins and subsequent re-excision after breast conserving surgery (BCS), many providers and facilities have implemented either a Full Cavity Shave (FCS) approach or adding th...

    Authors: Richard Gilmore, Jennifer Chen, Robert Dembinski, Yannis Reissis, David Milek, Lisa Cadena and Mehran Habibi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:66
  6. The aim of the study was to evaluate the cost-effectiveness of nivolumab plus chemotherapy as first-line treatment for patients with advanced gastric, gastroesophageal junction (GEJ), or esophageal adenocarcin...

    Authors: Peng-Fei Zhang, Xuan-Qiong Shi and Qiu Li
    Citation: Cost Effectiveness and Resource Allocation 2023 21:65
  7. To evaluate the cost-effectiveness ratio and economic impact of the Rapid Antigen Test (TR-Ag) to replace RT-PCR for the detection of the new Coronavirus in the Unified Health System (SUS).

    Authors: Vinicius Queiroz Miranda Cedro, Stéfany de Lima Gomes, Ana Clara Correa Duarte Simões, Tatiana do Valle Lovato Sverzut, Keila Cristina Xavier Bertti, Marcelo Tadeu Tristão, Yuri Wanderley Cavalcanti, João Victor Frazão Câmara and Antonio Carlos Pereira
    Citation: Cost Effectiveness and Resource Allocation 2023 21:64
  8. Acromioclavicular joint dislocations (ACD) are one of the most common shoulder injuries. There is no consensus in how to treat higher graded ACD ≥ Rockwood grade III. This study compares operative versus conse...

    Authors: Richard Niehaus, Alisa Schleicher, Elias Ammann, Philipp Kriechling, Christopher G. Lenz, Michael Masanneck, Sandro Hodel and Karim Eid
    Citation: Cost Effectiveness and Resource Allocation 2023 21:63

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:74

  9. Cost-effectiveness analysis (CEA) is a standard tool for evaluating health programs and informing decisions about resource allocation and prioritization. Most CEAs evaluating health interventions in low- and m...

    Authors: Joseph Corlis, Jinyi Zhu, Hélder Macul, Orrin Tiberi, Makini A. S. Boothe and Stephen C. Resch
    Citation: Cost Effectiveness and Resource Allocation 2023 21:62
  10. In December 2022, the Taiwan National Health Insurance Administration (NHIA) announced the reimbursement of three dosages of pemigatinib 4.5 mg, 9 mg, and 13.5 mg for treating advanced intrahepatic cholangioca...

    Authors: Zi-Rong Chen, Chen-Han Chueh, Nai-Jung Chiang and Yi-Wen Tsai
    Citation: Cost Effectiveness and Resource Allocation 2023 21:61
  11. To date, there have been no published studies evaluating the cost-effectiveness of robot-assisted gait training (RAGT) in adolescent and adult patients with cerebral palsy (CP). The study´s aim was to analyse ...

    Authors: Stanislava Klobucká, Robert Klobucký, Katarína Valovičová, Pavol Šiarnik and Branislav Kollár
    Citation: Cost Effectiveness and Resource Allocation 2023 21:60
  12. Chinese health system remains the crucial one for understanding the wider healthcare landscape across the Global South and in particular the leading Emerging Markets. Purpose of our observation was to understa...

    Authors: Mihajlo Jakovljevic, Hanyu Chang, Jay Pan, Chao Guo, Jin Hui, Hao Hu, Danko Grujic, Zhong Li and Lizheng Shi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:59
  13. Breast cancer is one of the main causes of death from cancer around the world, imposing a significant economic burden on the families and healthcare system. The present study aimed at determining the economic ...

    Authors: Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari and Ramin Ravangard
    Citation: Cost Effectiveness and Resource Allocation 2023 21:58

    The Correction to this article has been published in Cost Effectiveness and Resource Allocation 2023 21:71

  14. Policymakers in sub-Saharan Africa (SSA) face challenging decisions regarding the allocation of health resources. Economic evaluations can help decision makers to determine which health interventions should be...

    Authors: Samantha A Hollingworth, Glory-Anne Leaupepe, Justice Nonvignon, Ama Pokuaa Fenny, Emmanuel A. Odame and Francis Ruiz
    Citation: Cost Effectiveness and Resource Allocation 2023 21:57
  15. Authors: Federico Augustovski, Ariel Bardach, Adrián Santoro, Federico Rodriguez-Cairoli, Alejandro López-Osornio, Fernando Argento, Maissa Havela, Alejandro Blumenfeld, Jamile Ballivian, Germán Solioz, Analía Capula, Analía López, Cintia Cejas, William Savedoff, Alfredo Palacios, Adolfo Rubinstein…
    Citation: Cost Effectiveness and Resource Allocation 2023 21:56

    The original article was published in Cost Effectiveness and Resource Allocation 2023 21:21

  16. U.S. cost-effectiveness recommendations suggest that analyses should include all costs and effects relevant to the decision problem [1]. However, in many diseases, including spinal muscular atrophy (SMA), few stu...

    Authors: Abigail G. Riley, Christina M. Mulé, Debra Lerner, Lisa Belter, Colleen McCarthy O’Toole, Stacey Kowal, David Fox, Sheila Shapouri, Tamara Vesel and Tara A. Lavelle
    Citation: Cost Effectiveness and Resource Allocation 2023 21:55
  17. Iran government implemented the targeted subsidy plan in December 2010 to reduce energy consumption and inequality. In addition, the Health Transformation Plan was implemented by the Ministry of Health to redu...

    Authors: Yousef Mohammadzadeh, Aysan Sheikhmali, Jafar Yahyavi Dizaj, Ali Mohammad Mosadeghrad, Hasan Yusefzadeh and Arash Refah Kahriz
    Citation: Cost Effectiveness and Resource Allocation 2023 21:54
  18. In Morocco, hospitals do not have cost accounting systems that allow them to produce reliable budget forecasts to know and justify the costs of their operations. Moroccan hospitals are thus among the public or...

    Authors: A. Benabdallah and T. Jellouli
    Citation: Cost Effectiveness and Resource Allocation 2023 21:53
  19. The morbidity and mortality of adult diseases caused by S. pneumoniae increase with age and presence of underlying chronic diseases. Currently, two vaccine technologies against S. pneumoniae are used: the 23-vale...

    Authors: Mikkelsen Malene B, Husby Oyvind, Molden Tor, Mwaura David N, Olsen Jens, Kristensen Nanna V and Vietri Jeffrey
    Citation: Cost Effectiveness and Resource Allocation 2023 21:52
  20. Alzheimer's Disease (AD), the most common type of dementia, is a chronic, progressive, and neurodegenerative brain discomfort that causes the be damage to brain cells. Although there is no definitive treatment...

    Authors: Vahit Yigit, Selin Kalender and Iskender Cetinturk
    Citation: Cost Effectiveness and Resource Allocation 2023 21:51
  21. The Strategies to Reduce Injuries and Develop Confidence in Elders (STRIDE) Study cluster-randomized 86 primary care practices in 10 healthcare systems to a patient-centered multifactorial fall injury preventi...

    Authors: David A. Ganz, Thomas M. Gill, David B. Reuben, Shalender Bhasin, Nancy K. Latham, Peter Peduzzi and Erich J. Greene
    Citation: Cost Effectiveness and Resource Allocation 2023 21:49
  22. INES (INteractive model for Extrapolation of Survival and cost) provides an open-access tool powered by R that implements three-state partitioned survival models (PSM). This article describes the properties of...

    Authors: Vicente Gimeno-Ballester, Daniel Perez-Troncoso, Antonio Olry-Labry and David Epstein
    Citation: Cost Effectiveness and Resource Allocation 2023 21:48
  23. Breast cancer-related lymphedema (BCRL) imposes a significant economic burden on patients, providers, and society. There is no curative therapy for BCRL, but management through self-care can reduce symptoms an...

    Authors: Pinar Karaca-Mandic, Craig A. Solid, Jane M. Armer, Roman Skoracki, Elizabeth Campione and Stanley G. Rockson
    Citation: Cost Effectiveness and Resource Allocation 2023 21:47
  24. Stereotactic body radiotherapy (SBRT) is a novel radio-therapeutic technique that has recently emerged as standard-of-care treatment for medically inoperable, early-stage non-small cell lung cancer (NSCLC). In...

    Authors: Hui Sun, Huishan Wang, Yan Wei, Haiyin Wang, Chunlin Jin and Yingyao Chen
    Citation: Cost Effectiveness and Resource Allocation 2023 21:46
  25. Ceftazidime avibactam (CA) is an effective treatment against carbapenem-resistant Enterobacteriaceae (CRE), but its cost-effectiveness is unclear. This study was performed to evaluate the cost-effectiveness of...

    Authors: Zahra Goudarzi, Fattaneh Danayi, Khosro Keshavarz and Ahmad Gholami
    Citation: Cost Effectiveness and Resource Allocation 2023 21:45
  26. The Central Government of India introduced the National Health Mission (NHM) in 2005 to improve health outcomes by enhancing publicly financed (government) health expenditure and health infrastructure at the s...

    Authors: Ranjan Kumar Mohanty and Deepak Kumar Behera
    Citation: Cost Effectiveness and Resource Allocation 2023 21:44
  27. A health-economic evaluation related to COVID-19 is urgently needed to allocate healthcare resources efficiently; however, relevant medical cost data in Japan concerning COVID-19 are scarce.

    Authors: Shunsuke Uno, Rei Goto, Kimiko Honda, Machiko Tokuda, Hirofumi Kamata, Shotaro Chubachi, Ryo Yamamoto, Yukio Sato, Koichiro Homma, Sho Uchida, Ho Namkoong, Yoshifumi Uwamino, Junichi Sasaki, Koichi Fukunaga and Naoki Hasegawa
    Citation: Cost Effectiveness and Resource Allocation 2023 21:43
  28. In Colombia, the best strategy to establish indication for adjuvant chemotherapy in early breast cancer (EBC) remains unknown. This study aimed to identify the cost-utility of Oncotype DX™ (ODX) or Mammaprint™...

    Authors: Leonardo Rojas, María X. Rojas-Reyes, Diego Rosselli, Juan Guillermo Ariza, Alejandro Ruiz-Patiño and Andrés F. Cardona
    Citation: Cost Effectiveness and Resource Allocation 2023 21:42
  29. Diabetes is one of the most prevalent chronic diseases with subsequent complications. The positive effects of diabetes pay-for-performance (P4P) programs on treatment outcomes have been reported. The program p...

    Authors: Ming-Chan Sung, Kuo-Piao Chung and Shou-Hsia Cheng
    Citation: Cost Effectiveness and Resource Allocation 2023 21:41
  30. To estimate and compare the cost-effectiveness of COVID-19 critical care intervention approaches: noninvasive (oxygen without intubation) and invasive (intubation) management in Ethiopia.

    Authors: Senait Alemayehu Beshah, Arega Zeru, Wogayehu Tadele, Atkure Defar, Theodros Getachew and Lelisa Fekadu Assebe
    Citation: Cost Effectiveness and Resource Allocation 2023 21:40
  31. Cardiovascular diseases, such as stroke and ischemic heart disease attributable to hypertension, are major causes of premature death in Japan and worldwide. Nevertheless, a low rate of blood pressure control a...

    Authors: Narimasa Kumagai, Shuzo Nishimura and Mihajlo Jakovljević
    Citation: Cost Effectiveness and Resource Allocation 2023 21:39
  32. The duration of treatment (DOT) of the initial intervention and subsequent treatment is the key to determining the accuracy of anticancer-drug budget impact analysis (BIA) calculations. However, existing studi...

    Authors: Yue Ma, Jiting Zhou, Yuxin Ye, Aixia Ma and Hongchao Li
    Citation: Cost Effectiveness and Resource Allocation 2023 21:38
  33. The objective of this study was to estimate the willingness to pay (WTP) per quality-adjusted life year (QALY) among people with malignancies in China. The WTP for a QALY was estimated using a contingent valua...

    Authors: Li Huang, Xiaochen Peng, Lihua Sun and Dawei Zhang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:37
  34. Chronic obstructive pulmonary disease (COPD) is a progressive debilitating condition with frequent exacerbations that have a high burden for patients and society. Digital tools may help to reduce the economic ...

    Authors: Timothy J. Inocencio, Kimberly L. Sterling, Sibel Sayiner, Michael E. Minshall, Leanne Kaye and Umur Hatipoğlu
    Citation: Cost Effectiveness and Resource Allocation 2023 21:36
  35. Approximately 30–70% of patients who have undergone allogeneic (allo) hematopoietic stem cell transplantation (HSCT) eventually experience chronic graft-versus-host disease (cGVHD). Patients who develop steroi...

    Authors: Jian Chun Matthew Ong, Hein Than, Sandeep Tripathi, Christina Gkitzia and Xiaojun Wang
    Citation: Cost Effectiveness and Resource Allocation 2023 21:34
  36. Most cervical cancer patients in developing countries seek care in health facilities with an advanced disease, often characterized by obstructive uropathy. This study aims to estimate the cost of an image-guid...

    Authors: Amani Thomas Mori and Cecilia J. Nyabakari
    Citation: Cost Effectiveness and Resource Allocation 2023 21:33
  37. By evaluating equity and effectiveness, this study provides evidence-based knowledge for scientific decision-making and the optimization of magnetic resonance imaging (MRI) configuration and utilization at the...

    Authors: Xiaoling Huang, Yan Wei, Hui Sun, Jiaqi Huang, Yingyao Chen and Jingliang Cheng
    Citation: Cost Effectiveness and Resource Allocation 2023 21:32
  38. Economic analyses of healthcare interventions are an important consideration in evidence-based policymaking. A key component of such analyses is the costs of interventions, for which most are familiar with usi...

    Authors: Hugo C. Turner, Frank G. Sandmann, Laura E. Downey, Stacey Orangi, Yot Teerawattananon, Anna Vassall and Mark Jit
    Citation: Cost Effectiveness and Resource Allocation 2023 21:31
  39. The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures ag...

    Authors: Ariel Beresniak, Christian Napoli, John Oxford, Alejandra Daruich, Laurent Niddam, Gérard Duru, Alberto E. Tozzi, Marta Ciofi degli Atti, Danielle Dupont, Caterina Rizzo and Dominique Bremond-Gignac
    Citation: Cost Effectiveness and Resource Allocation 2023 21:30
  40. The aim of this study was to investigate the health and economic outcomes of a universal early intervention for parents and children, the Salut Programme, from birth to when the child completed five years of age.

    Authors: Filipa Sampaio, Jenny Häggström, Richard Ssegonja, Eva Eurenius, Anneli Ivarsson, Anni-Maria Pulkki-Brännström and Inna Feldman
    Citation: Cost Effectiveness and Resource Allocation 2023 21:29
  41. Thumb carpometacarpal (CMC) joint arthritis is one of the most prevalent arthritic conditions commonly treated with trapeziectomy alone or trapeziectomy with ligament reconstruction and tendon interposition (L...

    Authors: Alfred P. Yoon, David W. Hutton and Kevin C. Chung
    Citation: Cost Effectiveness and Resource Allocation 2023 21:28
  42. Different healthcare reforms could affect the productivity of hospitals. The aim of this study was to track hospital productivity before and after the recent Iranian healthcare reform in Khuzestan province, So...

    Authors: Sajad Vahedi, Mansour Zahiri, Narges Pirani and Amin Torabipour
    Citation: Cost Effectiveness and Resource Allocation 2023 21:26
  43. Understanding related risk factors of health-related quality of life (HRQoL) could avoid treatment failure and provide an insight of personalized treatment approach among people living with HIV/AIDS (PLWH). Th...

    Authors: Ming Guan and Hongyi Guan
    Citation: Cost Effectiveness and Resource Allocation 2023 21:25
  44. Authors: Mandy Maredza, Kamran Khan, Ioana R. Marian, Susan J. Dutton, Esther Williamson, Sarah E. Lamb and Stavros Petrou
    Citation: Cost Effectiveness and Resource Allocation 2023 21:24

    The original article was published in Cost Effectiveness and Resource Allocation 2023 21:14

  45. Increasing evidence has demonstrated the effectiveness and safety of vitamin D supplementation to prevent acute respiratory infections in children. More economic evaluations incorporating the new evidence and ...

    Authors: Jefferson Antonio Buendía and Diana Guerrero Patiño
    Citation: Cost Effectiveness and Resource Allocation 2023 21:23
  46. Informal care can reduce hospitalization frequency and time, elevate bed turnover, and increase the health systems' capacity. This type of care has shown meaningful value in managing many cases through the COV...

    Authors: Vajiheh Ramezani-Doroh, Faride Karimi, Maryam Rangchian and Yadolah Hamidi
    Citation: Cost Effectiveness and Resource Allocation 2023 21:22

Annual Journal Metrics

  • 2022 Citation Impact
    2.3 - 2-year Impact Factor
    2.4 - 5-year Impact Factor
    0.916 - SNIP (Source Normalized Impact per Paper)
    0.530 - SJR (SCImago Journal Rank)

    2023 Speed
    6 days submission to first editorial decision for all manuscripts (Median)
    157 days submission to accept (Median)

    2023 Usage 
    595,859 downloads
    2,584 Altmetric mentions